公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study | Ahn M.-J; Kim D.-W; Cho B.C; Kim S.-W; Lee J.S; Ahn J.-S; Kim T.M; CHIA-CHI LIN ; Kim H.R; John T; Kao S; Goldman J.W; Su W.-C; Natale R; Rabbie S; Harrop B; Overend P; Yang Z; CHIH-HSIN YANG | The Lancet Respiratory Medicine | 85 | 67 | |
2013 | Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines | D'Cruz A; Lin T; Anand A.K; Atmakusuma D; Calaguas M.J; Chitapanarux I; Cho B.C; Goh B.C; Guo Y; Hsieh W.S; Hu C; Kwong D; Lin J.C; PEI-JEN LOU ; Lu T; Prabhash K; Sriuranpong V; Tang P; Vu V.V; Wahid I; Ang K.K; Chan A.T. | Oral Oncology | 67 | 59 | |
2009 | First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009 | Soo R.A; Anderson B.O; Cho B.C; CHIH-HSIN YANG ; Liao M; Lim W.-T; Goldstraw P; Mok T.S. | The Lancet Oncology | 23 | 20 | |
2010 | The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer | Cho B.C; Kim J.H; Soo R.A; CHIH-HSIN YANG | Yonsei Medical Journal | 6 | 4 |